Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward individuals with substance abuse disorders. Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers. Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care. Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction, reduce the stigma toward addiction and improve the quality of health care.
Detailed description
PRIMARY OBJECTIVE: I. To describe the impact of SAS training on participants' responses to people with a substance impairment. SECONDARY OBJECTIVES: I. To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel. II. To explore the maintainability of responses over time. III. To explore relationships between language and stigmatizing attitudes. OUTLINE: Participants are randomized to 1 of 6 group case vignettes. GROUP A (CHRONICALLY RELAPSING BRAIN DISEASE): Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study. GROUP B (BRAIN DISEASE): Participants view the brain disease vignette and attend a SAS workshop on study. GROUP C (DISEASE): Participants view the disease vignette and attend a SAS workshop on study. GROUP D (ILLNESS): Participants view the illness vignette and attend a SAS workshop on study. GROUP E (DISORDER): Participants view the disorder vignette and attend a SAS workshop on study. GROUP F (PROBLEM): Participants view the problem vignette and attend a SAS workshop on study.
Interventions
Ancillary studies
View the chronically relapsing brain disease vignette
Attend a SAS workshop
Sponsors
Study design
Eligibility
Inclusion criteria
* Employee of Ohio State University Wexner Medical Center (OSUWMC) * Age ≥ 18 years * Participants must be able to read and comprehend survey items
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stigmatizing attitudes | Before, immediately after and 8 weeks after the session | Stigmatizing attitudes will be measured with the Stigma and Attribution Assessment. The assessment score will be compared both between and within participants for each case vignette. Results will be reported with descriptive statistics, including means and standard deviations or medians and first-third quartiles for continuous variables, and frequencies and percentages for discrete variables.The linear mixed effect model will be used to study the repeated stigma and attribution measures over time (pre-workshop, immediately post-workshop, and 8 weeks post-workshop) within 6 vignettes as well as the effects between the vignettes, while controlling for the potential confounding factors (e.g., sex). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Response to post-workshop evaluations | Before, immediately following and 8 weeks after the session. | The proportion of participants who respond to the post-workshop evaluations will be summarized with 95% confidence interval. |
| Attendance rate | At 90 minute session. | The proportion of participants attending the workshop will be summarized with 95% confidence interval. |
Countries
United States